Is there a future for ovulation induction in the current era of assisted reproduction?

Human Reproduction

Volumn 18, Issue 12, 2003, Pages 2499-2502

  Van Santbrink, E J P ^a   Fauser, B C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anovulation; FSH; Ovulation induction; Prediction model; Step down

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; ANDROSTENEDIONE; AROMATASE INHIBITOR; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GONADOTROPIN DERIVATIVE; INSULIN SENSITIZING AGENT; TESTOSTERONE; UNCLASSIFIED DRUG;

ALGORITHM; ANDROSTENEDIONE BLOOD LEVEL; ANOVULATION; BIRTH RATE; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; ESTRADIOL BLOOD LEVEL; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HUMAN; INDIVIDUALIZATION; INFERTILITY THERAPY; MASS SCREENING; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PATIENT CARE; PATIENT SELECTION; PREDICTION; PREGNANCY; REVIEW; TREATMENT OUTCOME;

EID: 0346777375     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg515     Document Type: Review

References (28)

1. Blankstein, J., Shalev, J., Saadon, T., Kukia, EE., Rabinovici, J., Pariente, C., Lunenfeld, B., Serr, D.M. and Mashiach, S. (1987) Ovarian hyperstimulation syndrome: Prediction by number and size of preovulatory ovarian follicles. Fertil. Steril., 47, 597-602.
2. Christin-Maitre, S., Hugues, J.N. on behalf of the recombinant FSH study group (2003) A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Hum. Reprod., 18, 1626-1631.
3. Dor, J., Itzkowic, D.J., Mashiach, S., Lunenfeld, B. and Serr, D.M. (1980) Cumulative conception rates following gonadotropin therapy. Am. J. Obstet. Gynecol., 136, 102-105.
4. Eijkemans, M.J., Imani, B., Mulders, A.G., Habbema, J.D. and Fauser, B.C. (2003) High singleton live birth rate following classical ovulation induction in normogonadotropic anovulatory infertility. Hum. Reprod., 18, in press.
5. ESHRE Capri Workshop Group (2003) Mono-ovulatory cycles: A key goal in profertility programmes. Hum. Reprod. Update, 9, 263-274.
6. Farquhar, C., Vandekerckhove, P. and Lilford, L. (2001) Laparascopic 'drilling' by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst. Rev., 4.
7. Haning, R.V., Austin, C.W., Carlston, I.H., Kuzma, D.L., Shapiro, S.S. and Zweibel, W.J. (1983) Plasma estradiol is superior to ultrasound and urinary estradiol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fertil. Steril., 40, 31-36.
8. Homburg, R. and Insler, V. (2002) Ovulation induction in perspective. Hum. Reprod. Update, 8, 449-462
9. Imani, B., Eijkemans, M.J., Te Velde, E.R., Habbema, J.D. and Fauser, B.C. (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J. Clin. Endocrinol. Metab., 83, 2361-2365.
10. Imani, B., Eijkemans, M.J., Te Velde, E.R., Habbema, J.D. and Fauser, B.C. (1999) Predictors of changes to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J. Clin. Endocrinol. Metab., 84, 1617-1622.
11. Imani, B., Eijkemans, M.J., De Jong, F., Payne, N.N., Bouchard, P., Giudice, L.C. and Fauser, B.C. (2000) Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J. Clin. Endocrinol. Metab., 85, 676-682.
12. Imani, B., Eijkemans, M.J., Te Velde, E.R., Habbema, J.D. and Fauser, B.C. (2002a) A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil. Steril., 77, 91-97.
13. Imani, B., Eijkemans, M.J., Faessen, G.H., Bouchard, P., Giudice, L.C. and Fauser, B.C. (2002b) Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: An approach to increase safety and efficiency. Fertil. Steril., 77, 83-90.
14. Jonard, S., Robert, Y., Cortet-Rudelli, C., Pigny, P., Decanter, C. and Dewailly, D. (2003) Ultrasound examination of polycystic ovaries: Is it worth counting the follicles? Hum. Reprod., 18, 598-603.
15. Lord, J.M., Flight, I.H.K. and Norman, R.J. (2003) Insulin-sensitizing drugs for polycystic ovary syndrome (Cochrane review). In: The Cochrane Library, Issue 3. Update Software, Oxford.
16. Mitwally, M.F. and Casper, R.F. (2003) Aromatase inhibitors for the treatment of infertility. Expert Opin. Invest. Drugs, 12, 353-371.
17. Mulders, A.G., Eijkemans, M.J., Imani, B. and Fauser, B.C.J.M. (2003a) Prediction of chances for success of complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reprod. Biomed. Online, 7, 48-56.
18. Mulders, A.G., Laven, S.J.L., Imani, B., Eijkemans, M.J. and Fauser, B.C.J.M. (2003b) IVF outcome in anovulatory infertility (WHO group 2) - Including polycystic ovary syndrome - Following previous unsuccessful ovulation induction. Reprod. Biomed. Online, 7, 50-58.
19. Mulders, A.G., Laven, S.J.L., Eijkemans, M.J., Hughes, E.G. and Fauser, B.C.J.M. (2003c) Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: A meta-analysis. Hum. Reprod. Update, in press.
20. Pirwany, I. and Tulandi, T. (2003) Laparoscopic treatment of polycystic ovaries: Is it time to relinquish the procedure. Fertil. Steril., 80, 241-251.
21. Schoot, D.C., Pache, T.D., Hop, W.C., DeJong, F.H. and Fauser, B.C. (1992) Growth patterns of ovarian follicles during induction of ovulation with decreasing doses of human menopausal gonadoropin following presumed selection in polycystic ovary syndrome. Fertil. Steril., 57, 1117-1120.
22. Van Der Meer, M.M., Hompes, P.G., De Boer, J.A., Schats, R. and Schoemaker, J. (1998) Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 83, 423-426.
23. Van Santbrink, E.J. and Fauser, B.C. (1997) Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: Prospective, randomized comparison between low dose step-up and step-down dose regimens. J. Clin. Endocrinol. Metab., 82, 3597-3602.
24. Van Santbrink, E.J., Hop, W.C., Van Dessel, T.J. and Fauser, B.C.J.M. (1995a) Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil. Steril., 64, 37-43.
25. Van Santbrink, E.J., Donderwinkel, F.J., Van Dessel, T.J. and Fauser, B.C.J.M. (1995b) Gonadotrophin induction of ovulation using a step-down dose regimen: Single-center clinical experience in 82 patients. Hum. Reprod., 10, 37-43.
26. Van Santbrink, Eijkemans, M.J., Macklon, N.S., Fauser, B.C.J.M. (2002) FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility. Eur. J. Endocrinol., 147, 223-226.
27. White, D.M., Polson, D.W., Kiddy, D. (1996) Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: An analysis of 109 pregnancies in 225 women. J. Clin. Endocrinol. Metab., 81, 3821-3824.
28. World Health Organization (1993) WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Cambridge University Press, Cambridge, UK.